Yi-Fen Lu

754 total citations · 1 hit paper
10 papers, 525 citations indexed

About

Yi-Fen Lu is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Yi-Fen Lu has authored 10 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Cell Biology. Recurrent topics in Yi-Fen Lu's work include Zebrafish Biomedical Research Applications (4 papers), Pluripotent Stem Cells Research (3 papers) and CAR-T cell therapy research (3 papers). Yi-Fen Lu is often cited by papers focused on Zebrafish Biomedical Research Applications (4 papers), Pluripotent Stem Cells Research (3 papers) and CAR-T cell therapy research (3 papers). Yi-Fen Lu collaborates with scholars based in United States, France and South Korea. Yi-Fen Lu's co-authors include George Q. Daley, Edroaldo Lummertz da Rocha, Erik Serrao, Patricia Sousa, Alan Engelman, R. Grant Rowe, Irene Wong, Mohan Malleshaiah, Scott B. Snapper and Sergei Doulatov and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Blood.

In The Last Decade

Yi-Fen Lu

10 papers receiving 520 citations

Hit Papers

Haematopoietic stem and progenitor cells from human pluri... 2017 2026 2020 2023 2017 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi-Fen Lu United States 8 362 212 139 121 73 10 525
Peter G. Kim United States 9 349 1.0× 265 1.3× 162 1.2× 135 1.1× 43 0.6× 13 537
JE Visvader Australia 6 537 1.5× 244 1.2× 212 1.5× 117 1.0× 110 1.5× 13 723
Teresa D’Altri Spain 10 450 1.2× 151 0.7× 150 1.1× 155 1.3× 99 1.4× 15 659
Yalin Guo Germany 9 269 0.7× 102 0.5× 122 0.9× 172 1.4× 62 0.8× 11 514
Kamaleldin E. Elagib United States 12 420 1.2× 154 0.7× 358 2.6× 105 0.9× 47 0.6× 19 697
Kristen D. McKnight Canada 9 372 1.0× 125 0.6× 269 1.9× 158 1.3× 75 1.0× 10 670
Aline M. Morrison Austria 7 253 0.7× 321 1.5× 209 1.5× 218 1.8× 55 0.8× 9 598
Raedun Clarke United States 8 227 0.6× 141 0.7× 64 0.5× 144 1.2× 106 1.5× 17 421
Laleh Talebian United States 8 406 1.1× 399 1.9× 203 1.5× 214 1.8× 52 0.7× 11 758
Guilherme Costa United Kingdom 12 397 1.1× 251 1.2× 108 0.8× 92 0.8× 29 0.4× 20 584

Countries citing papers authored by Yi-Fen Lu

Since Specialization
Citations

This map shows the geographic impact of Yi-Fen Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi-Fen Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi-Fen Lu more than expected).

Fields of papers citing papers by Yi-Fen Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi-Fen Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi-Fen Lu. The network helps show where Yi-Fen Lu may publish in the future.

Co-authorship network of co-authors of Yi-Fen Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yi-Fen Lu. A scholar is included among the top collaborators of Yi-Fen Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi-Fen Lu. Yi-Fen Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Dhanik, Ankur, Wei Keat Lim, Christina Adler, et al.. (2023). Spontaneous tumor regression mediated by human T cells in a humanized immune system mouse model. Communications Biology. 6(1). 444–444. 3 indexed citations
2.
Gupta, Namita, Davor Frleta, Tomasz B. Owczarek, et al.. (2023). Human CD4 cytotoxic T lymphocytes mediate potent tumor control in humanized immune system mice. Communications Biology. 6(1). 8 indexed citations
3.
Sugimura, Ryohichi, Deepak Kumar Jha, Areum Han, et al.. (2017). Haematopoietic stem and progenitor cells from human pluripotent stem cells. Nature. 545(7655). 432–438. 337 indexed citations breakdown →
4.
Sugimura, Ryohichi, Deepak Kumar Jha, Areum Han, et al.. (2017). Hematopoietic stem/progenitor cell conversion from human pluripotent stem cells. Protocol Exchange. 1 indexed citations
5.
Gao, Xiaofei, Hsiang‐Ying Lee, Edroaldo Lummertz da Rocha, et al.. (2016). TGF-β inhibitors stimulate red blood cell production by enhancing self-renewal of BFU-E erythroid progenitors. Blood. 128(23). 2637–2641. 40 indexed citations
6.
Lu, Yi-Fen, Patrick Cahan, Samantha Ross, et al.. (2016). Engineered Murine HSCs Reconstitute Multi-lineage Hematopoiesis and Adaptive Immunity. Cell Reports. 17(12). 3178–3192. 25 indexed citations
7.
Jang, Il Ho, Yi-Fen Lu, Long Zhao, et al.. (2015). Notch1 acts via Foxc2 to promote definitive hematopoiesis via effects on hemogenic endothelium. Blood. 125(9). 1418–1426. 34 indexed citations
8.
Kim, Peter G., Yi-Fen Lu, Il Ho Jang, et al.. (2012). Signaling axis involving Hedgehog, Notch, and Scl promotes the embryonic endothelial-to-hematopoietic transition. Proceedings of the National Academy of Sciences. 110(2). E141–50. 54 indexed citations
9.
Lu, Yi-Fen, L. Cristina Gavrilescu, Monica Betancur, et al.. (2011). Distinct graft-versus-leukemic stem cell effects of early or delayed donor leukocyte infusions in a mouse chronic myeloid leukemia model. Blood. 119(1). 273–284. 9 indexed citations
10.
Huang, Chiu-Chen, Yi-Fen Lu, Wen‐Chuan Hsieh, et al.. (2005). A novel apoptosis-inducing anti-PSGL-1 antibody for T cell-mediated diseases. European Journal of Immunology. 35(7). 2239–2249. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026